Role of Cardiovascular Magnetic Resonance in Cardiac Amyloidosis: A Narrative Review.
T1 mapping
T2 mapping
cardiac amyloidosis (CA)
cardiovascular magnetic resonance (CMR)
extracellular volume (ECV)
late gadolinium enhancement (LGE)
Journal
Journal of personalized medicine
ISSN: 2075-4426
Titre abrégé: J Pers Med
Pays: Switzerland
ID NLM: 101602269
Informations de publication
Date de publication:
11 Apr 2024
11 Apr 2024
Historique:
received:
17
03
2024
revised:
31
03
2024
accepted:
08
04
2024
medline:
27
4
2024
pubmed:
27
4
2024
entrez:
27
4
2024
Statut:
epublish
Résumé
Amyloidosis is a rare infiltrative condition resulting from the extracellular accumulation of amyloid fibrils at the cardiac level. It can be an acquired condition or due to genetic mutations. With the progression of imaging technologies, a non-invasive diagnosis was proposed. In this study, we discuss the role of CMR in cardiac amyloidosis, focusing on the two most common subtypes (AL and ATTR), waiting for evidence-based guidelines to be published.
Identifiants
pubmed: 38673034
pii: jpm14040407
doi: 10.3390/jpm14040407
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng